HUM Humana Inc. Common Stock
Про Humana Inc. Common Stock Огляд компанії з Wikipedia
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
Детальніше
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.
In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.
On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.
In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.
In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."
In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.
In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.
In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.
In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.
Corporate affairs
Sponsorship
Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.
Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.
Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.
The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.
In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.
On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
Джерело: Wikipedia (Англійська), CC BY-SA 4.0 · Переглянути на Wikipedia ↗
HUM Знімок акцій Ціна, ринкова капіталізація, P/E, EPS, ROE, борг/власний капітал, діапазон 52 тижнів
HUM Графік ціни акцій Денні OHLCV з технічними індикаторами — панування, масштабування та налаштування вашого представлення
10-річна ефективність Тренди виручки, чистого прибутку, маржі та EPS
Оцінка Співвідношення P/E, P/S, P/B, EV/EBITDA — акція дорога чи дешева?
Прибутковість Валова, операційна та чиста маржа; ROE, ROA, ROIC
Фінансове здоровʼя Борг, ліквідність, платоспроможність — міцність балансу
Зростання Зростання виручки, EPS та чистого прибутку: рік до року, 3-річний CAGR, 5-річний CAGR
Ефективність капіталу Оборотність активів, оборотність запасів, оборотність дебіторської заборгованості
Дивіденди Дивідендна дохідність, коефіцієнт виплат, історія дивідендів, 5-річний CAGR
| Дата екс-дивіденду | Сума |
|---|---|
| 26 червня 2026 р. | $0,8850 |
| 27 березня 2026 р. | $0,8850 |
| 26 грудня 2025 р. | $0,8850 |
| 26 вересня 2025 р. | $0,8850 |
| 27 червня 2025 р. | $0,8850 |
| 28 березня 2025 р. | $0,8850 |
| 31 грудня 2024 р. | $0,8850 |
| 30 вересня 2024 р. | $0,8850 |
| 28 червня 2024 р. | $0,8850 |
| 27 березня 2024 р. | $0,8850 |
| 28 грудня 2023 р. | $0,8850 |
| 28 вересня 2023 р. | $0,8850 |
| 29 червня 2023 р. | $0,8850 |
| 30 березня 2023 р. | $0,8850 |
| 29 грудня 2022 р. | $0,7880 |
| 29 вересня 2022 р. | $0,7880 |
| 29 червня 2022 р. | $0,7880 |
| 30 березня 2022 р. | $0,7880 |
| 30 грудня 2021 р. | $0,7000 |
| 29 вересня 2021 р. | $0,7000 |
HUM Консенсус аналітиків Бичачі та ведмежі думки аналітиків, 12-місячна цільова ціна, потенціал зростання
- Активна купівля 8 24,2%
- Купівля 8 24,2%
- Утримувати 15 45,5%
- Продаж 2 6,1%
- Активний продаж 0 0,0%
12-місячна цільова ціна
23 аналітиків · 2026-08-19Історія прибутків EPS фактичний проти прогнозу, сюрприз %, коефіцієнт перевищення, дата наступного звіту про прибутки
| Період | EPS Actual | EPS прогноз | Сюрприз |
|---|---|---|---|
| 30 червня 2026 р. | $7.61 | $7.29 | 0.32% |
| 31 березня 2026 р. | $10.31 | $10.29 | 0.02% |
| 31 грудня 2025 р. | $-3.96 | $-4.05 | 0.09% |
| 30 вересня 2025 р. | $3.24 | $2.85 | 0.39% |
| 30 червня 2025 р. | $6.27 | $5.98 | 0.29% |
| 31 березня 2025 р. | $11.58 | $10.17 | 1.4% |
Порівняння з аналогами (підгалузь GICS) Ключові показники порівняно з аналогами в секторі
| Тікер | Капіталізація | P/E | Виручка рік до року | Чиста маржа | ROE | Валова маржа |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Повні фундаментальні показники Усі показники за роками — звіт про прибутки та збитки, баланс, рух грошових коштів
Звіт про прибутки та збитки 13
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Баланс 26
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Грошовий потік 17
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Прибутковість 7
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Ліквідність та платоспроможність 5
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Ефективність 2
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Темпи зростання 10
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Оцінка (TTM) 17
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Звіт про прибутки та збитки 13
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | -241,024,000 | 120,273,000 | 120,539,000 | 120,666,000 | -241,257,000 | 120,405,000 | 120,445,000 | 120,978,000 | -249,139,000 | 123,426,000 | 124,574,000 | 125,005,000 | -253,614,000 | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | -241,508,000 | 120,745,000 | 120,745,000 | 120,844,000 | -241,828,000 | 120,764,000 | 120,665,000 | 121,268,000 | -250,215,000 | 123,983,000 | 125,109,000 | 125,564,000 | -254,820,000 | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Баланс 25
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Грошовий потік 17
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Прибутковість 7
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Ліквідність та платоспроможність 5
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Ефективність 2
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Оцінка (TTM) 15
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.55B | $136.80B | · | $126.55B | $123.44B | $120.66B | · | $114.97B | $112.32B | $109.52B | · | $102.71B | $99.95B | $97.17B | · | $91.13B | |
| Net Income TTM | $2.62B | $3.17B | · | $2.46B | $2.95B | $3.14B | · | $2.73B | $3.21B | $3.77B | · | $4.22B | $4.09B | $4.06B | · | $4.35B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 18.3 | 6.6 | · | 12.7 | 10.0 | 10.2 | · | 14.1 | 14.3 | 11.4 | · | 14.5 | 13.8 | 15.2 | · | 14.3 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| P / FCF | · | 30.4 | · | · | · | 222.8 | · | · | · | 280.0 | · | · | · | 14.9 | · | · | |
| EV / EBITDA | 49.3 | 14.1 | · | 105.5 | 35.9 | 21.4 | · | 69.6 | 55.3 | 47.5 | · | 62.9 | 46.7 | 45.1 | · | 66.1 | |
| EV / FCF | · | 21.9 | · | · | · | 182.9 | · | · | · | 238.5 | · | · | · | 12.0 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.9 | |
| Earnings Yield | 5.5% | 15.2% | · | 7.8% | 10.0% | 9.8% | · | 7.1% | 7.0% | 8.8% | · | 6.9% | 7.2% | 6.6% | · | 7.0% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · |
Фінансова звітність Звіт про прибутки та збитки, баланс, рух грошових коштів — річні, за останні 5 років
Звіт про прибутки та збитки
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Виручка | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Операційна маржа % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Чистий прибуток | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| Розбавлений EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
Баланс
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Борг / Власний капітал | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Поточний коефіцієнт | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Коефіцієнт швидкої ліквідності | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
Грошовий потік
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Вільний грошовий потік | $375M | $2.39B | $2.98B | $3.47B | $946M |
Останні новини Останні заголовки, що згадують цю компанію
Мої показники Ваш персональний список спостереження — вибрані рядки з Повних фундаментальних даних
Виберіть показники, які для вас важливі — натисніть ➕ поруч із будь-яким рядком у Повних фундаментальних даних вище.
Ваш вибір збережено і він буде застосовуватися до всіх тікерів.
Інституційні власники (13F) 1 050 подавачів звітності · $33.7B всього · Станом на 30 червня 2026 р.
Інституційні інвестори, які звітують про володіння цими акціями у своїй квартальній формі SEC 13F. Тільки довгі позиції; один подавець звітності може з'явитися двічі для окремих опціонних контрактів. Великі протилежні опціонні позиції (пут/кол) зазвичай відображають маркет-мейкінг або хеджування запасів, а не спрямованість переконань.
| Нові позиції | Закриті позиції | Збільшено | Зменшено | Зміна чистих акцій |
|---|---|---|---|---|
| 255 (+143 проти попереднього кв.) | 81 (-80 проти попереднього кв.) | 313 (+42 проти попереднього кв.) | 273 (-45 проти попереднього кв.) | +23.7M |
Порівняно з Q1 2026. Звіти SEC Form 13F подаються протягом 45 днів після закінчення кварталу плюс невеликий буфер для тих, хто подає із запізненням — квартали, що ще знаходяться в цьому вікні, пропускаються на користь останньої повністю звітної пари.
| Інституційний інвестор | Вартість | Акції | % від відстежуваного 13F | Тип |
|---|---|---|---|---|
| Dodge & Cox | $4 345 737 744 | 10 940 380 | 12,90% | Акції |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 115 642 737 | 7 843 620 | 9,25% | Акції |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 311 405 702 | 5 818 956 | 6,86% | Акції |
| STATE STREET CORP | $2 172 441 313 | 5 457 072 | 6,45% | Акції |
| EAGLE CAPITAL MANAGEMENT LLC | $1 528 010 749 | 3 846 762 | 4,54% | Акції |
| Sessa Capital IM, L.P. | $1 480 732 883 | 3 727 740 | 4,40% | Акції |
| GEODE CAPITAL MANAGEMENT, LLC | $1 181 074 714 | 2 976 242 | 3,51% | Акції |
| Capital International Investors | $950 462 637 | 2 392 826 | 2,82% | Акції |
| NAYA CAPITAL MANAGEMENT UK LTD | $728 407 339 | 1 833 763 | 2,16% | Акції |
| NORGES BANK | $694 505 009 | 1 748 414 | 2,06% | Акції |
| GOLDMAN SACHS GROUP INC | $659 096 868 | 1 659 274 | 1,96% | Акції |
| FMR LLC | $615 633 048 | 1 549 854 | 1,83% | Акції |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544 502 820 | 1 370 784 | 1,62% | Акції |
| Capital Research Global Investors | $443 462 035 | 1 116 990 | 1,32% | Акції |
| Slate Path Capital LP | $428 969 795 | 1 079 930 | 1,27% | Акції |
| Capital World Investors | $406 119 738 | 1 022 425 | 1,21% | Акції |
| Newport Trust Company, LLC | $384 768 345 | 968 653 | 1,14% | Акції |
| CITADEL ADVISORS LLC | $363 376 856 | 914 800 | 1,08% | Опціон кол |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348 908 912 | 878 377 | 1,04% | Акції |
| DIMENSIONAL FUND ADVISORS LP | $331 490 508 | 834 526 | 0,98% | Акції |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314 921 577 | 792 814 | 0,93% | Акції |
| CITADEL ADVISORS LLC | $310 904 094 | 782 700 | 0,92% | Опціон пут |
| WELLINGTON MANAGEMENT GROUP LLP | $282 117 958 | 710 231 | 0,84% | Акції |
| VANGUARD FIDUCIARY TRUST CO | $267 791 027 | 674 163 | 0,79% | Акції |
| Maple Rock Capital Partners Inc. | $249 553 862 | 628 251 | 0,74% | Акції |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245 555 446 | 618 185 | 0,73% | Акції |
| GOLDMAN SACHS GROUP INC | $232 333 978 | 584 900 | 0,69% | Опціон кол |
| MARSHALL WACE, LLP | $216 873 381 | 545 978 | 0,64% | Акції |
| CITADEL ADVISORS LLC | $178 080 082 | 448 316 | 0,53% | Акції |
| High Ground Investment Management LLP | $177 941 848 | 447 968 | 0,53% | Акції |
| 1832 Asset Management L.P. | $176 401 430 | 444 090 | 0,52% | Акції |
| BCV Asset Management Inc. | $173 695 656 | 445 719 | 0,52% | Акції |
| BANK OF AMERICA CORP /DE/ | $172 703 708 | 434 781 | 0,51% | Акції |
| Holocene Advisors, LP | $165 040 541 | 415 489 | 0,49% | Акції |
| BNP PARIBAS FINANCIAL MARKETS | $147 490 964 | 371 308 | 0,44% | Акції |
| MILLENNIUM MANAGEMENT LLC | $140 098 700 | 352 698 | 0,42% | Акції |
| JANE STREET GROUP, LLC | $137 080 622 | 345 100 | 0,41% | Опціон кол |
| Swiss National Bank | $134 522 525 | 338 660 | 0,40% | Акції |
| JANE STREET GROUP, LLC | $122 542 370 | 308 500 | 0,36% | Опціон пут |
| STEADFAST CAPITAL MANAGEMENT LP | $122 423 204 | 308 200 | 0,36% | Акції |
| BlackRock, Inc. | $120 890 332 | 304 341 | 0,36% | Акції |
| Mitsubishi UFJ Asset Management Co., Ltd. | $115 565 201 | 290 935 | 0,34% | Акції |
| VANGUARD ASSET MANAGEMENT, Ltd | $109 135 401 | 274 748 | 0,32% | Акції |
| AMERIPRISE FINANCIAL INC | $108 302 217 | 272 614 | 0,32% | Акції |
| Legal & General Group Plc | $103 424 967 | 260 372 | 0,31% | Акції |
| Vanguard Global Advisers, LLC | $103 330 825 | 260 135 | 0,31% | Акції |
| GOLDMAN SACHS GROUP INC | $103 078 590 | 259 500 | 0,31% | Опціон пут |
| NEUBERGER BERMAN GROUP LLC | $102 585 352 | 258 258 | 0,30% | Акції |
| BANK OF NOVA SCOTIA | $102 313 941 | 257 575 | 0,30% | Акції |
| RHUMBLINE ADVISERS | $102 294 748 | 257 527 | 0,30% | Акції |
| Sumitomo Mitsui Trust Group, Inc. | $101 464 685 | 255 437 | 0,30% | Акції |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $100 979 680 | 254 216 | 0,30% | Акції |
| Gotham Asset Management, LLC | $89 318 889 | 224 860 | 0,27% | Акції |
| Balyasny Asset Management L.P. | $87 965 958 | 221 454 | 0,26% | Акції |
| FIRST TRUST ADVISORS LP | $85 094 587 | 214 226 | 0,25% | Акції |
| Ensign Peak Advisors, Inc | $83 532 585 | 210 293 | 0,25% | Акції |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $83 463 866 | 210 120 | 0,25% | Акції |
| Brandywine Global Investment Management, LLC | $80 388 706 | 313 859 | 0,24% | Акції |
| California Public Employees Retirement System | $80 274 587 | 202 091 | 0,24% | Акції |
| WOLVERINE TRADING, LLC | $76 135 109 | 298 300 | 0,23% | Опціон кол |
| Camber Capital Management LP | $73 344 000 | 300 000 | 0,22% | Акції |
| National Pension Service | $70 860 473 | 178 391 | 0,21% | Акції |
| BARCLAYS PLC | $70 472 788 | 177 415 | 0,21% | Акції |
| Susquehanna Portfolio Strategies, LLC | $69 949 250 | 176 097 | 0,21% | Акції |
| Walleye Trading LLC | $69 473 778 | 174 900 | 0,21% | Опціон кол |
| CANADA PENSION PLAN INVESTMENT BOARD | $68 018 761 | 171 237 | 0,20% | Акції |
| ARGA Investment Management, LP | $66 165 730 | 166 572 | 0,20% | Акції |
| ORBIMED ADVISORS LLC | $65 183 802 | 164 100 | 0,19% | Акції |
| Solel Partners LP | $64 742 888 | 162 990 | 0,19% | Акції |
| AMF Tjanstepension AB | $61 961 951 | 155 989 | 0,18% | Акції |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $60 794 124 | 153 049 | 0,18% | Акції |
| Perpetual Ltd | $57 945 659 | 145 878 | 0,17% | Акції |
| CI INVESTMENTS INC. | $57 302 560 | 144 259 | 0,17% | Акції |
| AMERICAN CENTURY COMPANIES INC | $56 575 256 | 142 426 | 0,17% | Акції |
| Squarepoint Ops LLC | $56 047 742 | 141 100 | 0,17% | Опціон пут |
| Aberdeen Group plc | $53 345 852 | 134 298 | 0,16% | Акції |
| WOLVERINE TRADING, LLC | $52 653 949 | 206 300 | 0,16% | Опціон пут |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $52 178 000 | 131 358 | 0,15% | Акції |
| ING GROEP NV | $51 583 784 | 129 862 | 0,15% | Акції |
| Squarepoint Ops LLC | $50 685 272 | 127 600 | 0,15% | Опціон кол |
| Walleye Trading LLC | $49 573 056 | 124 800 | 0,15% | Опціон пут |
| D. E. Shaw & Co., Inc. | $46 514 462 | 117 100 | 0,14% | Опціон кол |
| BRAIDWELL LP | $45 481 690 | 114 500 | 0,14% | Акції |
| Jain Global LLC | $43 694 200 | 110 000 | 0,13% | Опціон пут |
| BANK OF MONTREAL /CAN/ | $43 207 208 | 108 774 | 0,13% | Акції |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42 190 325 | 106 214 | 0,13% | Акції |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $42 127 167 | 106 055 | 0,13% | Акції |
| AVIVA PLC | $41 509 093 | 104 499 | 0,12% | Акції |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $41 468 472 | 161 904 | 0,12% | Акції |
| ROYAL BANK OF CANADA | $41 033 000 | 103 301 | 0,12% | Акції |
| Pentwater Capital Management LP | $39 722 000 | 100 000 | 0,12% | Опціон кол |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39 284 661 | 98 899 | 0,12% | Акції |
| Point72 Asset Management, L.P. | $39 122 595 | 98 491 | 0,12% | Акції |
| PFM Health Sciences, LP | $37 487 638 | 94 375 | 0,11% | Акції |
| Summit Street Capital Management, LLC | $36 325 372 | 91 449 | 0,11% | Акції |
| Columbus Hill Capital Management, L.P. | $35 501 935 | 89 376 | 0,11% | Акції |
| Korea Investment CORP | $34 579 193 | 87 053 | 0,10% | Акції |
| Quantinno Capital Management LP | $32 817 091 | 82 616 | 0,10% | Акції |
| Fisher Funds Management LTD | $32 811 563 | 82 603 | 0,10% | Акції |
| Swedbank AB | $32 034 603 | 80 647 | 0,10% | Акції |
Інсайдери компанії 76 інсайдерів · 46 керівники · 27 директори
| Інсайдер | Роль | Остання активність | Кількість акцій у власності | Купівлі за 12 міс. | Продажі за 12 міс. | Нетто 12 міс |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 14 травня 2025 р. P | 30 474 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 21 лютого 2024 р. A | 110 130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 24 лютого 2025 р. A | 29 676 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 31 грудня 2024 р. J | 20 165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 22 лютого 2021 р. A | 24 342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 09 травня 2014 р. G | 14 916 | 0 | 0 | $0 |
| George Renaudin II | President, Insurance | 27 березня 2025 р. J | 15 702 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 24 лютого 2025 р. A | 16 234 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 24 лютого 2025 р. A | 11 566 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 24 лютого 2023 р. A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 15 грудня 2022 р. M | 3 983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 15 грудня 2017 р. M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 18 лютого 2014 р. A | 105 443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 31 березня 2017 р. J | 34 668 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 24 лютого 2025 р. A | 8 628 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 24 лютого 2025 р. A | 1 767 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 24 лютого 2025 р. A | 11 266 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 24 лютого 2025 р. A | 17 267 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 24 лютого 2025 р. A | 16 717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 31 грудня 2024 р. G | 7 111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 15 грудня 2024 р. M | 14 015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 лютого 2024 р. A | 11 723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 24 лютого 2023 р. F | 3 687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 01 травня 2022 р. M | 4 294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 22 березня 2022 р. J | 5 723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 25 лютого 2022 р. F | 6 014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 16 березня 2021 р. G | 8 168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 18 грудня 2019 р. M | 18 092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 15 грудня 2019 р. M | 6 339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 25 лютого 2019 р. A | 9 774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 19 лютого 2019 р. M | 10 791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 15 грудня 2018 р. M | 11 136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 15 грудня 2018 р. M | 6 476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 17 березня 2017 р. M | 4 361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 18 лютого 2014 р. A | 1 101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 18 лютого 2014 р. A | 15 946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 24 червня 2013 р. M | 19 347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 24 грудня 2012 р. G | 2 287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 28 квітня 2012 р. F | 11 946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 23 лютого 2012 р. A | 23 280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 04 лютого 2009 р. I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 27 березня 2008 р. J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 25 лютого 2008 р. F | 13 836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 31 грудня 2007 р. I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 23 лютого 2007 р. M | 57 548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 06 січня 2005 р. M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Директор | 30 червня 2026 р. A | 19 448 | 0 | 0 | $0 |
| Frank A Damelio | Директор | 02 січня 2026 р. A | 20 634 | 0 | 0 | $0 |
| Karen Katz | Директор | 31 грудня 2025 р. A | 590 | 0 | 0 | $0 |
| David T Feinberg | Директор | 30 червня 2025 р. A | 441 | 0 | 0 | $0 |
Інсайдери згідно з формами SEC 3/4/5; чистий результат = лише відкритий ринок купівлі/продажу
Активісти та власники %+ 5 1 холдинг
Інвестори, які подали Розклад SEC 13D — бенефіціарна власність понад 5% з наміром вплинути на емітента (активістські частки, кампанії в раді директорів, M&A). Кожен рядок показує останній відомий стан позиції цього подавця.
| Подавець | Подано | Частка | Статус | Мета | Подача |
|---|---|---|---|---|---|
| David A. Jones ×2 подання | 12 листопада 2003 р. | — | Первинна подача | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Присутність в ETF Належить 200 ETF
Вага відображає лише прямі акціонерні володіння (N-PORT); фонди з кредитним плечем або похідними інструментами можуть мати додаткову експозицію за свопами, яка не відображається.
| Фонд | Вага | Одиниці | Станом на | Джерело |
|---|---|---|---|---|
| IHF · iShares Trust | 4,29% | 144 763 SH | 08 серпня 2026 р. | Щоденно |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,95% | 109 132 NS | 30 квітня 2026 р. | N-PORT |
| SMRI · EA Series Trust | 2,54% | 58 016 NS | 30 квітня 2026 р. | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,27% | 100 446 SH | 08 серпня 2026 р. | Щоденно |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2,26% | 2 111 NS | 30 квітня 2026 р. | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,80% | 11 546 SH | 08 серпня 2026 р. | Щоденно |
| SRHQ · Elevation Series Trust | 1,63% | 13 322 NS | 30 квітня 2026 р. | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,60% | 32 564 SH | 08 серпня 2026 р. | Щоденно |
| CVAR · ETF Opportunities Trust | 1,51% | 2 473 NS | 30 квітня 2026 р. | N-PORT |
| EPMV · Harbor ETF Trust | 1,20% | 225 NS | 30 квітня 2026 р. | N-PORT |
| ABCS · EA Series Trust | 1,19% | 441 NS | 29 травня 2026 р. | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1,14% | 17 702 NS | 31 травня 2026 р. | N-PORT |
| NUMV · Nushares ETF Trust | 0,96% | 17 434 NS | 30 квітня 2026 р. | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,95% | 52 223 NS | 30 квітня 2026 р. | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,82% | 771 237 SH | 08 серпня 2026 р. | Щоденно |
| ITAN · EA Series Trust | 0,77% | 2 259 NS | 29 травня 2026 р. | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,72% | 65 925 NS | 31 травня 2026 р. | N-PORT |
| IYH · iShares Trust | 0,72% | 71 884 SH | 08 серпня 2026 р. | Щоденно |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,71% | 183 164 SH | 08 серпня 2026 р. | Щоденно |
| VHT · VANGUARD WORLD FUND | 0,70% | 360 880 SH | 08 серпня 2026 р. | Щоденно |
| AUSF · Global X Funds | 0,70% | 19 401 NS | 31 травня 2026 р. | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,63% | 211 NS | 31 травня 2026 р. | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,59% | 30 459 NS | 30 квітня 2026 р. | N-PORT |
| IXJ · iShares Trust | 0,56% | 62 953 SH | 08 серпня 2026 р. | Щоденно |
| RXL · ProShares Trust | 0,53% | 1 258 NS | 31 травня 2026 р. | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,47% | 2 755 NS | 30 квітня 2026 р. | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,46% | 2 601 869 SH | 08 серпня 2026 р. | Щоденно |
| FHLC · FIDELITY COVINGTON TRUST | 0,46% | 55 439 NS | 30 квітня 2026 р. | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,45% | 28 340 NS | 30 квітня 2026 р. | N-PORT |
| DEUS · DBX ETF Trust | 0,43% | 3 849 NS | 29 травня 2026 р. | N-PORT |
| IWS · iShares Trust | 0,42% | 181 221 SH | 08 серпня 2026 р. | Щоденно |
| CURE · Direxion Shares ETF Trust | 0,41% | 2 404 NS | 30 квітня 2026 р. | N-PORT |
| SPXD · DBX ETF Trust | 0,37% | 81 NS | 31 травня 2026 р. | N-PORT |
| IMCV · iShares Trust | 0,36% | 11 394 SH | 08 серпня 2026 р. | Щоденно |
| QARP · DBX ETF Trust | 0,36% | 887 NS | 29 травня 2026 р. | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 0,35% | 10 520 000 | 08 серпня 2026 р. | Щоденно |
| PRF · Invesco Exchange-Traded Fund Trust | 0,35% | 90 057 SH | 08 серпня 2026 р. | Щоденно |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,34% | 4 484 NS | 31 травня 2026 р. | N-PORT |
| GMOV · GMO ETF Trust | 0,34% | 1 004 NS | 31 травня 2026 р. | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0,32% | 265 500 NS | 31 травня 2026 р. | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,32% | 7 839 SH | 08 серпня 2026 р. | Щоденно |
| IWR · iShares Trust | 0,32% | 489 015 SH | 08 серпня 2026 р. | Щоденно |
| IMCB · iShares Trust | 0,30% | 13 840 SH | 08 серпня 2026 р. | Щоденно |
| FNDB · SCHWAB STRATEGIC TRUST | 0,29% | 12 439 NS | 31 травня 2026 р. | N-PORT |
| PALC · Pacer Funds Trust | 0,29% | 2 779 NS | 30 квітня 2026 р. | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,28% | 1 250 NS | 31 травня 2026 р. | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,28% | 320 000 | 08 серпня 2026 р. | Щоденно |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0,27% | 299 NS | 31 травня 2026 р. | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0,26% | 12 272 NS | 30 квітня 2026 р. | N-PORT |
| VLUE · iShares Trust | 0,24% | 62 558 SH | 08 серпня 2026 р. | Щоденно |